pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,664 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT800Endpoints604BioPharma Dive231onclive165Fierce Biotech74BioSpace69raps29
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology
  • Planning a successful pivot from lab to clinic
    For sterile injectables, key early decisions can have a significant impact on the products’ development.
    BioPharma Dive · 1mo ago↗ source
  • Opinion: In many South Asian American families, a child’s autism diagnosis is a secret
    “In South Asian households, a child's disability triggers a specific kind of family crisis,” writes child and adolescent psychiatrist Ritu Goel.
    STAT · 1mo ago↗ source
  • Opinion: I’m a pediatrician. I want to prescribe the right AI to my patients
    AI for children requires “randomized controlled trials measuring real developmental outcomes, not engagement metrics,” writes Dua Hassan.
    STAT · 1mo ago↗ source
← prev
page 30 of 67
next →
6
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
  • STAT+: One California politician’s unexpected crusade against ultra-processed food
    Jesse Gabriel "has passed more food policy in three years than most legislators enact in their entire careers," says one supporter.
    STAT · 1mo ago↗ source
  • STAT+: Amid confusion over Pfizer’s emergency penicillin program, newborn is diagnosed with preventable syphilis
    Congenital syphilis should be preventable. An Arizona case shows how drug shortages and procedural hurdles are fueling a growing public health crisis.
    STAT · 1mo ago↗ source
  • As states follow Trump’s Medicaid fraud playbook, people with disabilities struggle to find care
    Medicaid cuts and fraud crackdown trickle down to states, threatening people with disabilities.
    STAT · 1mo ago↗ source
  • HMNC Brain Health raises $50M Series B to advance two depression drugs
    HMNC Brain Health has secured $50 million in a Series B fundraise designed to support two psychiatry programs into mid-stage studies. The family-owned German drugmaker Medice led the Series B, whic…
    Endpoints · 1mo ago↗ source
  • STAT+: FDA approves Sanofi diabetes drug for children with stage 3 diabetes
    The FDA has approved a drug that was previously caught in a dispute between career staff and the political appointee head of the CDER.
    STAT · 1mo ago↗ source
  • WHO director-general is profoundly concerned after visit to Ebola outbreak area
    The director-general of the World Health Organization is profoundly worried about the Ebola outbreak in the DRC, he told STAT in an interview.
    STAT · 1mo ago↗ source
  • Biopharma’s 2025 industry pay report; Parabilis sets industry record IPO; and more
    Welcome back to Endpoints Weekly! This week, we opened nominations for our eighth annual Women in Biopharma report. We’re looking to profile 20 scientists, executives, founders and other enterprisi…
    Endpoints · 1mo ago↗ source
  • Opinion: ‘I’m pretty much all in’: An interview with a woman starting medical residency at almost 73
    "There are some physicians that work to 100”: Dawn Zuidgeest-Craft on becoming a medical doctor in her 70s.
    STAT · 1mo ago↗ source
  • STAT+: Trump administration revisits policy to close Medicare drug price negotiation loophole
    Trump administration revisits policy to plug Medicare drug price negotiation loophole.
    STAT · 1mo ago↗ source
  • Merck brings Welireg-Keytruda combo to treat kidney cancer
    Merck’s Welireg and Keytruda combination won approval as an adjuvant treatment for kidney cancer patients after surgery to remove all or part of the organ. The combination was approved Friday for ...
    Endpoints · 1mo ago↗ source
  • Amgen and the FDA want two different outcomes for Tavneos. What will patients do?
    Amgen has asked the FDA to review evidence that its drug Tavneos (avacopan), which treats a rare form of vasculitis, is worth keeping on the market, as the future of the drug remains in flux. ...
    Endpoints · 1mo ago↗ source
  • Eli Lilly invests in startup Abridge for clinical trial recruitment
    Eli Lilly has invested in Abridge as the health tech startup expands into clinical trial recruitment and broadens its reach into the life sciences. The investment, made through Lilly’s venture arm,…
    Endpoints · 1mo ago↗ source
  • STAT+: Up and down the ladder: The latest comings and goings
    From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
    STAT · 1mo ago↗ source
  • Enliven prices $400M offering; Jazz drug Zepzelca fails confirmatory study
    Plus news about Caribou, Adial, and the Beneluxa Initiative. 💵 Enliven Therapeutics’ data and raise: The Burlingame, CA-based biotech priced a $400 million offering {$ELVN} Thursday night after sa…
    Endpoints · 1mo ago↗ source
  • STAT+: Prometheus raises $12 billion in capital for artificial engineers
    Nonprofit Blood Cancer United acquires cancer drug, Lilly and Nvidia invest in Abridge, and more biotech news
    STAT · 1mo ago↗ source
  • Biopharma's pay oddities of 2025: Executive perks and eccentricities
    In combing through thousands of C-suite pay packages worth billions of dollars, it’s rare for a line item to stick out. Every once in a while, a biopharma company discloses perks that go beyond the…
    Endpoints · 1mo ago↗ source
  • Rapport ‘fully prepared’ to launch seizure drug solo, CEO says
    In a wide-ranging interview, Abe Ceesay detailed how Rapport built an investor syndicate and why the company is confident it can join the ranks of successful, commercial-stage brain drugmakers.
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and more
    The nonprofit Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug, Luvelta
    STAT · 1mo ago↗ source
  • Chile offers new data on food warning label efficacy
    Kennedy's "publicly" "available" "calendar," drinking during pregnancy, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • WuXi AppTec sues Pentagon in challenge over inclusion on Chinese military list
    WuXi AppTec has lodged a claim against the Department of Defense following its addition to a list of companies associated with the Chinese military. Under the complaint, filed Thursday with the US…
    Endpoints · 1mo ago↗ source
  • GSK took advantage of ASCO dip to get discount on Nuvalent
    GSK’s $10.6 billion buyout of Nuvalent, announced Tuesday, was the largest in the company’s history. But did new CEO Luke Miels get a discount? At $124 a share, the price Miels paid ...
    Endpoints · 1mo ago↗ source
  • Novo's M&A leader leaves for Forbion; Perrigo CEO's 'personal conduct' issues led to resignation
    Forbion’s portfolio companies have been no stranger to M&A deals in recent years. But the Dutch investment firm now wants more of its biotechs to benefit from the industry’s ...
    Endpoints · 1mo ago↗ source